C83.14 Mantle cell lymphoma, lymph nodes of axilla and upper limb

Name of the Condition

• Mantle cell lymphoma, lymph nodes of axilla and upper limb
• Also known as ICD-10 code C83.14

Summary

Mantle cell lymphoma, lymph nodes of axilla and upper limb, is a type of non-Hodgkin lymphoma characterized by the malignant proliferation of B-cells originating from the mantle zone of lymphoid follicles. It specifically involves abnormal growth of these cells in the lymph nodes of the axilla and upper limb regions. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior.

Causes

The exact cause of mantle cell lymphoma, lymph nodes of axilla and upper limb, remains unknown. It is thought to involve genetic mutations, such as the t(11;14)(q13;q32) translocation, which leads to overexpression of cyclin D1. Specific triggers or environmental factors are not well-defined, though research suggests potential links to immune system dysregulation.

Risk Factors

• Age: More common in older adults, typically over 60 years.
• Male gender: Slightly higher incidence in males.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the axilla or upper limb.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI), and biopsy of the affected lymph nodes. Laboratory tests, including blood work and flow cytometry, may be used to confirm the presence of malignant B-cells and assess disease extent. Staging helps determine the spread of the lymphoma.

Treatment Options

Treatment may include chemotherapy, targeted therapy, immunotherapy, or radiation therapy, depending on the stage and patient factors. Clinical trials or stem cell transplantation may be considered for advanced cases. Treatment plans are individualized based on the patient’s overall health and disease characteristics.

Prognosis and Follow-Up

Prognosis varies based on the stage at diagnosis, response to treatment, and patient age. Regular follow-up with imaging and laboratory tests is essential to monitor for recurrence or progression. Long-term surveillance is recommended to detect late effects or secondary malignancies.

Complications

Potential complications include infection due to immunosuppression, organ dysfunction from lymphoma infiltration, or treatment-related side effects (e.g., cytopenias, neuropathy). Advanced disease may lead to systemic symptoms or impaired mobility if lymph nodes in the upper limb are significantly enlarged.

Lifestyle & Prevention

No specific preventive measures are known. Maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known carcinogens (e.g., tobacco) may support overall health. Patients should avoid unnecessary immunosuppression and seek prompt care for infections.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes in the axilla or upper limb, unexplained weight loss, fever, or night sweats. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Use code C83.14 for mantle cell lymphoma specifically involving the lymph nodes of the axilla and upper limb. Ensure documentation specifies the anatomical site to support code assignment. Review clinical notes for confirmation of the lymphoma type and location to avoid miscoding.